• Follow
  • Follow
  • Menu Item

Log in

Subscribe Today
G2 Intelligence
  • Industry Perspectives
  • Industry News
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Subscriber Articles
    • Editor Exclusives
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LAB INDUSTRY REPORT

NATIONAL LAB REPORTER

Above-Market Lease with Landlord Doctors Costs BioReference $9.85 Million

Above-Market Lease with Landlord Doctors Costs BioReference $9.85 Million

by Glenn S. Demby | Jul 28, 2022 | Lab Compliance Advisor, Labs in Court-lca

In this month’s Labs in Court roundup, BioReference pays big to settle kickback allegations, among several other kickback-related cases.

This content is for Paid Members only.
Login Join Now
How to Guard Your Lab from Telehealth Liability Risk

How to Guard Your Lab from Telehealth Liability Risk

by Glenn S. Demby | Jul 26, 2022 | Enforcement-lca, Lab Compliance Advisor

The OIG’s new Fraud Alert can help labs and other providers steer clear of potentially suspect arrangements with telemedicine companies.

This content is for Paid Members only.
Login Join Now
Does Offering Free Access to Drug Pricing Tool Cross the Kickback Line?

Does Offering Free Access to Drug Pricing Tool Cross the Kickback Line?

by Glenn S. Demby | Jun 2, 2022 | Articles, News, Open Content

NY federal court ruling sheds light on what constitutes “remuneration” banned by the Anti-Kickback Statute.

OIG Gives the OK to Free Genetic Testing & Counseling Arrangement

OIG Gives the OK to Free Genetic Testing & Counseling Arrangement

by Glenn S. Demby | May 30, 2022 | Articles, Compliance Guidance-lca, Lab Compliance Advisor

New OIG Advisory Opinion offers valuable insight into where the agency draws the line on free genetic tests.

This content is for Paid Members only.
Login Join Now
Recent Kickback Cases Range from $300 Million Scheme to a Free Service

Recent Kickback Cases Range from $300 Million Scheme to a Free Service

by Glenn S. Demby | May 30, 2022 | Articles, Lab Compliance Advisor, Labs in Court-lca

Of this month’s four Labs in Court cases, three involved kickbacks resulting in widely varying penalties.

This content is for Paid Members only.
Login Join Now
« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Privacy Policy
  • Terms
  • About Us
    • G2 Intelligence Team
    • Contact Us
  • Homepage
  • FAQ
Copyright © 2022 G2 Intelligence.com